November 5, 2025
1 min read

AstraZeneca adds $136M investment to Chinese inhalants plant

AstraZeneca is pouring $136 million more into the expansion of an inhalants production base in China, bringing its total investment at the site to $886 million.

Leave a Reply

Your email address will not be published.

Previous Story

Making protein accessible: Quick commerce steps up to meet India’s nutrition gap – The Times of India

Next Story

Remote Health Monitoring Increases Doctors’ Ability To See More Patients

Previous Story

Making protein accessible: Quick commerce steps up to meet India’s nutrition gap – The Times of India

Next Story

Remote Health Monitoring Increases Doctors’ Ability To See More Patients

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop